Bioelectronics Corp (BIEL)

[kidnova]

Color, when you spoke with him did you inquire as to which major Canadian retailers were carrying the product as you reported in early February?

My phone interview with Andy Today:

1) Scarsdale Equity is not being compensated with shares of stock. They are being paid cash and a percentage based on their performance.

BIEL hired them because they have the clout to move companies ahead and BIEL wants to aggressively expand.They feel strongly that they are now in a strong position to attract a partner or more financing,that is another reason Scarsdale decided to take BIEL on.It takes more money to expose to the mass market.Andy has had a 25 year relationship with the head of this firm,and Scarsdale feels they can move BIEL's product line forward. That is why they agreed to a percentage deal.They have to produce to make money. However,they are being paid a small cash sum also.

2)FDA - Andy has been in touch with the FDA regularly. The FDA has been requesting small info. requests , Andy feels approval is very close.
RecoveryRx™ is most likely to be approved first,then Allay and Actipatch.

3)Canada sales are getting stronger and BIEL.Several major retailers are now going to carry the products...this is very good news.
4)Uk Allay sales are doing extremely well...so far better than expected....

5) BIEL is not diluting shares

I hopes this helps clear the air a little bit...remember to do your own DD to make any of your decisions.